ArticleThe Journal of pharmacology and experimental therapeutics2022

Pharmacokinetics and Safety Studies in Rodent Models Support Development of EPICERTIN as a Novel Topical Wound-Healing Biologic for Ulcerative Colitis.

Daniel Tusé et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.